Hematologic Oncology Update cover image

Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting

Hematologic Oncology Update

00:00

Is There a Sick Inhibitor in CLL?

Sick inhibitors do sick as associated with FLIT-3 and ZAP-70. It actually has rheumatological indications as well. So yeah, so I think it's pleotropicly active. Now we're going to look at some long term follow up or the of the mentalist trial in patients with a ring sitter blast low risk AML. The primary endpoint was met, whereas the loose batter step had a significant decrease in their eight week transfusion independent rate.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app